Blog
About

6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Inhibition of T and B lymphocyte proliferation by rapamycin.

      Immunology

      Anti-Bacterial Agents, pharmacology, B-Lymphocytes, immunology, Cell Division, drug effects, Cells, Cultured, Cyclosporins, Drug Interactions, Immunosuppressive Agents, Lymphocyte Activation, Tacrolimus, Male, Mice, Mice, Inbred CBA, Mitogens, Polyenes, Sirolimus, Swine, T-Lymphocytes, Animals

      Read this article at

      ScienceOpenPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The immunosuppressive macrolide rapamycin shows marked structural similarity to FK-506, and like FK-506 inhibits the activation of cultured T and B lymphocytes at concentrations as low as 10(-10) M. However, rapamycin blocks T-lymphocyte proliferation at a much later stage than FK-506. It also inhibits human, porcine and murine T- and B-lymphocyte activation by all pathways tested, including pathways which are insensitive to FK-506, such as interleukin-2 (IL-2)-mediated proliferation of IL-2-dependent T-cell lines, activation of human peripheral blood T lymphocytes by phorbol ester and anti-CD28 and activation of murine B lymphocytes by bacterial lipopolysaccharide. Thus these two macrolides that bind competitively to the same major intracellular receptor protein inhibit T- and B-lymphocyte activation by quite distinct mechanisms.

          Related collections

          Author and article information

          Journal
          1709916
          1384375

          Comments

          Comment on this article